Increased AICD generation does not result in increased nuclear translocation or activation of target gene transcription.

[1]  Yvonne S. Eisele,et al.  Gleevec increases levels of the amyloid precursor protein intracellular domain and of the amyloid-beta degrading enzyme neprilysin. , 2007, Molecular biology of the cell.

[2]  A. Delacourte,et al.  Alkalizing Drugs Induce Accumulation of Amyloid Precursor Protein By-products in Luminal Vesicles of Multivesicular Bodies* , 2007, Journal of Biological Chemistry.

[3]  Huaxi Xu,et al.  Presenilin/γ-secretase-dependent processing of β-amyloid precursor protein regulates EGF receptor expression , 2007, Proceedings of the National Academy of Sciences.

[4]  Jiuhong Kang,et al.  Receptor tyrosine kinases positively regulate BACE activity and Amyloid-β production through enhancing BACE internalization , 2007, Cell Research.

[5]  Dieter Langosch,et al.  GxxxG motifs within the amyloid precursor protein transmembrane sequence are critical for the etiology of Aβ42 , 2007 .

[6]  A. Delacourte,et al.  Intracellular pH regulates amyloid precursor protein intracellular domain accumulation , 2007, Neurobiology of Disease.

[7]  P. George-Hyslop,et al.  Response to Correspondence: Pardossi-Piquard et al., “Presenilin-Dependent Transcriptional Control of the Aβ-Degrading Enzyme Neprilysin by Intracellular Domains of βAPP and APLP.” Neuron 46, 541–554 , 2007, Neuron.

[8]  F. Kametani,et al.  Aβ 11–40/42 production without γ-secretase ε-site cleavage , 2006 .

[9]  F. G. van der Goot,et al.  Intra-endosomal membrane traffic. , 2006, Trends in cell biology.

[10]  C. Pietrzik,et al.  Functional Role of the Low-Density Lipoprotein Receptor-Related Protein in Alzheimer’s Disease , 2006, Neurodegenerative Diseases.

[11]  B. Hyman,et al.  GGA1 Acts as a Spatial Switch Altering Amyloid Precursor Protein Trafficking and Processing , 2006, The Journal of Neuroscience.

[12]  P. Verkade,et al.  Alzheimer's disease beta-amyloid peptides are released in association with exosomes. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[13]  S. Hébert,et al.  Regulated intramembrane proteolysis of amyloid precursor protein and regulation of expression of putative target genes , 2006, EMBO reports.

[14]  P. S. St George-Hyslop,et al.  Presenilin-Dependent γ-Secretase-Mediated Control of p53-Associated Cell Death in Alzheimer's Disease , 2006, The Journal of Neuroscience.

[15]  Y. Ihara,et al.  Equimolar Production of Amyloid β-Protein and Amyloid Precursor Protein Intracellular Domain from β-Carboxyl-terminal Fragment by γ-Secretase* , 2006, Journal of Biological Chemistry.

[16]  C. Behl,et al.  Oestrogen receptor subtype‐specific repression of calpain expression and calpain enzymatic activity in neuronal cells – implications for neuroprotection against Ca2+‐mediated excitotoxicity , 2006, Journal of neurochemistry.

[17]  D. Barrick,et al.  The Notch Transcription Activation Complex Makes Its Move , 2006, Cell.

[18]  B. Yankner,et al.  A γ-Secretase-independent Mechanism of Signal Transduction by the Amyloid Precursor Protein* , 2005, Journal of Biological Chemistry.

[19]  B. Hyman,et al.  APP substitutions V715F and L720P alter PS1 conformation and differentially affect Aβ and AICD generation , 2005, Journal of neurochemistry.

[20]  B. Hyman,et al.  BACE Is Degraded via the Lysosomal Pathway* , 2005, Journal of Biological Chemistry.

[21]  B. Hyman,et al.  Low Density Lipoprotein Receptor-related Protein (LRP) Interacts with Presenilin 1 and Is a Competitive Substrate of the Amyloid Precursor Protein (APP) for γ-Secretase* , 2005, Journal of Biological Chemistry.

[22]  B. Winchester,et al.  Lysosomal metabolism of glycoproteins. , 2005, Glycobiology.

[23]  C. Behl,et al.  Concepts for the treatment of Alzheimer's disease: molecular mechanisms and clinical application , 2005, International journal of experimental pathology.

[24]  F. Checler,et al.  Presenilin-Dependent Transcriptional Control of the Aβ-Degrading Enzyme Neprilysin by Intracellular Domains of βAPP and APLP , 2005, Neuron.

[25]  F. Kametani,et al.  Longer Forms of Amyloid β Protein: Implications for the Mechanism of Intramembrane Cleavage by γ-Secretase , 2005, The Journal of Neuroscience.

[26]  T. Südhof,et al.  Proteolytic Processing of Amyloid-β Precursor Protein by Secretases Does Not Require Cell Surface Transport* , 2004, Journal of Biological Chemistry.

[27]  A. Goate,et al.  Mutations in APP have independent effects on Aβ and CTFγ generation , 2004, Neurobiology of Disease.

[28]  R. Nitsch,et al.  The APP intracellular domain forms nuclear multiprotein complexes and regulates the transcription of its own precursor , 2004, Journal of Cell Science.

[29]  T. Südhof,et al.  Dissection of Amyloid-β Precursor Protein-dependent Transcriptional Transactivation* , 2004, Journal of Biological Chemistry.

[30]  T. Iwatsubo.  The γ-secretase complex: machinery for intramembrane proteolysis , 2004, Current Opinion in Neurobiology.

[31]  Sascha Weggen,et al.  FE65 Constitutes the Functional Link between the Low-Density Lipoprotein Receptor-Related Protein and the Amyloid Precursor Protein , 2004, The Journal of Neuroscience.

[32]  D. Selkoe,et al.  Notch and Presenilin: regulated intramembrane proteolysis links development and degeneration. , 2003, Annual review of neuroscience.

[33]  S. Weggen,et al.  Aβ42-lowering Nonsteroidal Anti-inflammatory Drugs Preserve Intramembrane Cleavage of the Amyloid Precursor Protein (APP) and ErbB-4 Receptor and Signaling through the APP Intracellular Domain* , 2003, Journal of Biological Chemistry.

[34]  Sascha Weggen,et al.  The cytoplasmic domain of the LDL receptor‐related protein regulates multiple steps in APP processing , 2002, The EMBO journal.

[35]  Christopher K. Glass,et al.  Exchange of N-CoR Corepressor and Tip60 Coactivator Complexes Links Gene Expression by NF-κB and β-Amyloid Precursor Protein , 2002, Cell.

[36]  G. Horgan,et al.  Relative expression software tool (REST©) for group-wise comparison and statistical analysis of relative expression results in real-time PCR , 2002 .

[37]  S. Green,et al.  Endosomal Sorting of Amyloid Precursor Protein‐P‐Selectin Chimeras Influences Secretase Processing , 2001, Traffic.

[38]  D. Selkoe,et al.  The Intracellular Domain of the β-Amyloid Precursor Protein Is Stabilized by Fe65 and Translocates to the Nucleus in a Notch-like Manner* , 2001, The Journal of Biological Chemistry.

[39]  Y. Ihara,et al.  Distinct Intramembrane Cleavage of the β-Amyloid Precursor Protein Family Resembling γ-Secretase-like Cleavage of Notch* , 2001, The Journal of Biological Chemistry.

[40]  S. Heck,et al.  Estrogen induces a rapid secretion of amyloid beta precursor protein via the mitogen-activated protein kinase pathway. , 2001, European journal of biochemistry.

[41]  Thomas C. Südhof,et al.  A Transcriptively Active Complex of APP with Fe65 and Histone Acetyltransferase Tip60 , 2001, Science.

[42]  M. Wolfe,et al.  The Role of Presenilins in γ-Secretase Activity* , 2001, The Journal of Biological Chemistry.

[43]  T. Golde,et al.  The FASEB Journal express article 10.1096/fj.00-0286fje. Published online October 6, 2000. Cell-free assays for γ-secretase activity , 2022 .

[44]  R. Katzman.,et al.  Modulation of amyloid beta-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway. , 2000, The Journal of clinical investigation.

[45]  R. Doms,et al.  Maturation and Endosomal Targeting of β-Site Amyloid Precursor Protein-cleaving Enzyme , 2000, The Journal of Biological Chemistry.

[46]  Graeme Irvine Stevenson,et al.  L-685,458, an Aspartyl Protease Transition State Mimic, Is a Potent Inhibitor of Amyloid β-Protein Precursor γ-Secretase Activity , 2000 .

[47]  Min Xu,et al.  Photoactivated γ-secretase inhibitors directed to the active site covalently label presenilin 1 , 2000, Nature.

[48]  David G. Tew,et al.  Identification of a Novel Aspartic Protease (Asp 2) as β-Secretase , 1999, Molecular and Cellular Neuroscience.

[49]  John Calvin Reed,et al.  Mechanisms of Transcriptional Activation of bcl-2Gene Expression by 17β-Estradiol in Breast Cancer Cells* , 1999, The Journal of Biological Chemistry.

[50]  J. Treanor,et al.  Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. , 1999, Science.

[51]  N. Hooper,et al.  Cleavage of Alzheimer's amyloid precursor protein by alpha-secretase occurs at the surface of neuronal cells. , 1999, Biochemistry.

[52]  C. Masters,et al.  A novel substrate for analyzing Alzheimer's disease γ‐secretase , 1999 .

[53]  William J. Ray,et al.  A presenilin-1-dependent γ-secretase-like protease mediates release of Notch intracellular domain , 1999, Nature.

[54]  F. Schweisguth,et al.  Indirect evidence for Delta-dependent intracellular processing of Notch in Drosophila embryos , 1998, Current Biology.

[55]  Raphael Kopan,et al.  Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain , 1998, Nature.

[56]  G. Struhl,et al.  Nuclear Access and Action of Notch In Vivo , 1998, Cell.

[57]  P. Paganetti,et al.  Effect of alkalizing agents on the processing of the β-amyloid precursor protein , 1996, Brain Research.

[58]  D. Lahiri.  Effect of ionophores on the processing of theβ-amyloid precursor protein in different cell lines , 1994, Cellular and Molecular Neurobiology.

[59]  S. Squazzo,et al.  Evidence that production and release of amyloid beta-protein involves the endocytic pathway. , 1994, The Journal of biological chemistry.

[60]  D. Selkoe,et al.  beta-Amyloid peptide and a 3-kDa fragment are derived by distinct cellular mechanisms. , 1993, The Journal of biological chemistry.

[61]  S. Estus,et al.  Production of the Alzheimer amyloid beta protein by normal proteolytic processing. , 1992, Science.

[62]  P. Greengard,et al.  Chloroquine inhibits intracellular degradation but not secretion of Alzheimer beta/A4 amyloid precursor protein. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[63]  D. Selkoe,et al.  Processing of the amyloid protein precursor to potentially amyloidogenic derivatives. , 1992, Science.

[64]  Y. Moriyama,et al.  Bafilomycin A1, a specific inhibitor of vacuolar-type H(+)-ATPase, inhibits acidification and protein degradation in lysosomes of cultured cells. , 1991, The Journal of biological chemistry.

[65]  D. Price,et al.  Evidence that beta-amyloid protein in Alzheimer's disease is not derived by normal processing. , 1990, Science.

[66]  P. Seglen,et al.  Effects of lysosomotropic monoamines, diamines, amino alcohols, and other amino compounds on protein degradation and protein synthesis in isolated rat hepatocytes. , 1980, Molecular pharmacology.

[67]  F. Kametani,et al.  Intracellular domain generation of amyloid precursor protein by ε-cleavage depends on C-terminal fragment by α-secretase cleavage , 2004 .

[68]  D L Price,et al.  New perspectives on Alzheimer's disease. , 1986, Annual review of neuroscience.